This insider cluster is routine and non-informative for a $225B mega-cap. The dollar amounts are trivial relative to market cap, and the sales are likely liquidity-driven (option exercises, tax planning). No actionable trading signal. Monitor next quarterly earnings for fundamental updates.
Price Chart
Executive Summary
Three Amgen senior VPs (CCO, Business Development, Human Resources) sold a total of ~$2.45M in open-market shares over a 5-day window, with an additional SVP exercising and immediately selling options. The total sales represent ~0.001% of Amgen's $225B market cap — a trivial amount. Director grants (non-cash) also occurred in the same period. The selling is routine for a mega-cap and lacks material signal, especially given the small dollar amounts relative to company size and the presence of option-exercise-related sales.
Key Financial Metrics
Key Facts
- Three SVP-level executives sold a combined ~$2.45M in open-market shares between Aug 4-11, 2026
- SVP Khosla Rachna also exercised and immediately sold 1,252 shares on Aug 13, 2026
- Four directors/executives received non-cash stock grants on Aug 7, 2026 (total ~983 shares, $0 value)
- Total open-market sales represent ~0.001% of Amgen's $225B market cap — well below any materiality threshold
- Historical calibration on AMGN shows a 25% win rate at T+20 across 8 settled reports, with avg alpha of -5.25% vs SPY
Financial Impact
Total insider open-market sales of ~$2.45M, representing ~0.001% of market cap — immaterial
Risk Factors
- Insider selling pattern could intensify if fundamental headwinds emerge
- Historical AMGN reports show poor predictive accuracy (25% win rate at T+20) — past neutral calls have underperformed SPY by -5.25% alpha
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-AMGN-1786662364489 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | ANALYST-DOWNGRADE | $382.47 $379.78 | ▲ +0.70% | ▲ +0.20% | $403.04 (−5.38%) |
Sep 8, 2026 24d ago | ANALYST-DOWNGRADE | $393.17 $375.65 | ▲ +4.46% | ▲ +3.34% | $403.04 (−2.51%) |
Aug 14, 2026 7w ago | Court Ruling | $415.21 $439.33 | ▲ +5.81% | ▲ +7.18% | $403.04 (−2.93%) |
Aug 13, 2026 7w ago | Insider Cluster | $415.21 $439.33 | ▲ +5.81% | ▲ +7.18% | $403.04 (−2.93%) |
Aug 11, 2026 7w ago | Court Ruling | $414.30 $425.28 | ▲ +2.65% | ▲ +3.05% | $403.04 (−2.72%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $403.04 (−3.39%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $403.04 (−3.39%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $403.04 (−3.39%) |
Aug 4, 2026 8w ago | GOVT-CONTRACT | $390.02 $414.30 | ▲ +6.23% | ▲ +6.33% | $403.04 (+3.34%) |
Jul 31, 2026 9w ago | 8-K | $378.87 $417.20 | ▼ −10.12% | ▼ −8.09% | $403.04 (−6.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access